Assessment of vitamin D levels in patients with oral potentially malignant disorders and oral squamous cell carcinoma-A cross-sectional study
- PMID: 38130424
- PMCID: PMC10733696
- DOI: 10.1016/j.jobcr.2023.11.005
Assessment of vitamin D levels in patients with oral potentially malignant disorders and oral squamous cell carcinoma-A cross-sectional study
Abstract
Objectives: The aim of this study was to assess and compare the serum and salivary levels of Vitamin D in patients with oral potentially malignant disorders (OPMD) and Oral squamous cell carcinoma (OSCC) with healthy controls.
Method: This cross-sectional study was carried out among 60 patients reporting to the department of Oral Medicine and Radiology, and included patients with OPMDs, OSCC and healthy controls. The Vitamin D levels were estimated using the chemiluminescence immunoassay. One-way ANOVA was used to compare mean and statistical difference between the groups. Tukey's post HOC test calculated for inter group difference. Serum and salivary Vitamin D levels were corelated with Pearson's coefficient. The values of p < 0.005 was considered as significant.
Results: The levels of Vitamin D were decreased in study group as compared to controls both in serum and saliva. (p < 0.001). Between serum and salivary Vitamin D levels, a strong association was discovered using the Pearson's coefficient value of 0.737 (p < 0.001).
Conclusion: In this study, patients with both OPMDs and OSCC had Vitamin D insufficiency & deficiency. Vitamin D level assessment should be included as a standard component of routine investigations for these individuals.
Keywords: Precancerous conditions; Saliva; Squamous cell carcinoma of head and neck; Vitamin D deficiency.
© 2023 Published by Elsevier B.V. on behalf of Craniofacial Research Foundation.
Conflict of interest statement
Nil.
Figures





Similar articles
-
Evaluation of Salivary Interleukin-6 in Patients with Oral Squamous Cell Carcinoma, Oral Potentially Malignant Disorders, Chronic Periodontitis and in Healthy Controls - A Cross-Sectional Comparative Study.Ann Maxillofac Surg. 2023 Jan-Jun;13(1):70-75. doi: 10.4103/ams.ams_240_22. Epub 2023 Jul 26. Ann Maxillofac Surg. 2023. PMID: 37711518 Free PMC article.
-
Sialic acid as a biomarker of oral potentially malignant disorders and oral cancer.Indian J Dent Res. 2017 Jul-Aug;28(4):395-399. doi: 10.4103/ijdr.IJDR_632_16. Indian J Dent Res. 2017. PMID: 28836530
-
Assessment of serum synuclein-γ and squamous cell carcinoma antigen as diagnostic biomarkers in patients with oral squamous cell carcinoma and oral potentially malignant disorders.J Oral Pathol Med. 2021 Feb;50(2):165-174. doi: 10.1111/jop.13115. Epub 2020 Oct 29. J Oral Pathol Med. 2021. PMID: 33064859
-
Hypovitaminosis D, oral potentially malignant disorders, and oral squamous cell carcinoma: a systematic review.Med Oral Patol Oral Cir Bucal. 2022 Mar 1;27(2):e135-e141. doi: 10.4317/medoral.25049. Med Oral Patol Oral Cir Bucal. 2022. PMID: 35218642 Free PMC article.
-
Comparison of Salivary Electrolytes Profile in Oral Potentially Malignant Disorders and Oral Squamous Cell Carcinoma.Asian Pac J Cancer Prev. 2022 Mar 1;23(3):1031-1039. doi: 10.31557/APJCP.2022.23.3.1031. Asian Pac J Cancer Prev. 2022. PMID: 35345377 Free PMC article.
Cited by
-
Hypovitaminosis D in patients with oral leukoplakia: insights from a cross-sectional study.Front Oncol. 2025 Feb 6;15:1522726. doi: 10.3389/fonc.2025.1522726. eCollection 2025. Front Oncol. 2025. PMID: 39980554 Free PMC article.
-
Association of vitamin D levels and oral lichen planus. Systematic review and meta-analysis.Med Oral Patol Oral Cir Bucal. 2024 Sep 1;29(5):e626-e633. doi: 10.4317/medoral.26603. Med Oral Patol Oral Cir Bucal. 2024. PMID: 38907640 Free PMC article.
-
Hypovitaminosis D in patients with oral squamous cell carcinoma: Is a risk factor of developing this neoplasia?Med Oral Patol Oral Cir Bucal. 2025 Jan 1;30(1):e24-e30. doi: 10.4317/medoral.26692. Med Oral Patol Oral Cir Bucal. 2025. PMID: 39582404 Free PMC article.
-
Prevalence and Causes of Vitamin D Deficiency in a Cohort of Greek HIV-Infected Individuals: A Prospective, Single Center, Observational Study.Curr HIV Res. 2024;22(4):240-248. doi: 10.2174/011570162X302844240605104855. Curr HIV Res. 2024. PMID: 38874038
References
-
- Prabhash K., Babu G., Chaturvedi P., et al. Indian clinical practice consensus guidelines for the management of OSCC of head and neck. Indian J Cancer. 2020;57:S1–S5. - PubMed
-
- Kallalli B.N., Rawson K., Muzammil Singh A., Awati M.A., Shivhare P., et al. Lactate dehydrogenase as a biomarker in oral cancer and oral submucous fibrosis. J Oral Pathol Med. 2016;45:687–690. - PubMed
-
- Warnakulasuriya S., Kujan O., Aguirre-Urizar J.M., et al. Oral potentially malignant disorders: a consensus report from an international seminar on nomenclature and classification, convened by the WHO Collaborating Centre for OSCC. Oral Dis. 2021;27:1862–1880. - PubMed
-
- Christakos S., Dhawan P., Liu Y., Peng X., Porta A. New insights into the mechanisms of Vitamin D action. J Cell Biochem. 2003;88(4):695–705. - PubMed